Phathom Pharmaceuticals, Inc. (PHAT)

11.74 -1.14 (-8.85%) USD  |  NASDAQ  |  Apr 22, 16:00
11.78 +0.04 (+0.34%) After-Hours: 20:00
More

Phathom Pharmaceuticals Outperform Recommendations

Outperform Recommendations Chart

View Outperform Recommendations for PHAT.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Outperform Recommendations Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Outperform Recommendations Range, Past 5 Years

View Outperform Recommendations Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Outperform Recommendations Benchmarks

View Outperform Recommendations Benchmarks
Start Trial
Replimune Group, Inc. Upgrade
ANI Pharmaceuticals, Inc. Upgrade
MannKind Corp. Upgrade
Ocugen, Inc. Upgrade
Ligand Pharmaceuticals, Inc. Upgrade